UK study highlights importance of GP data in understanding atrial fibrillation
The common heart condition affects approximately 1.5 million people in the UK
Read Moreby Emily Kimber | Feb 19, 2025 | News | 0
The common heart condition affects approximately 1.5 million people in the UK
Read Moreby Jen Brogan | Nov 3, 2023 | News | 0
Since 2022, an estimated 17,000 strokes and 4,000 deaths have been prevented
Read Moreby John Pinching | Mar 14, 2023 | News | 0
Candidate AP30663 is an inhibitor for the conversion of atrial fibrillation to a normal sinus rhythm
Read Moreby John Pinching | Feb 22, 2023 | News | 0
Research will analyse how Huawei’s wearable technology detects atrial fibrillation in post-stroke patients
Read Moreby Lucy Parsons | Apr 28, 2021 | News | 0
Updated clinical guideline on the diagnosis and management of AF addresses several new areas
Read Moreby Lucy Parsons | Mar 23, 2021 | News | 0
Collaborative agreement will focus on improving detection and diagnosis of AF
Read Moreby Anna Smith | Jul 23, 2019 | News | 0
The Oberoi SPAF & Case Finding Service ensures high-risk AF patients receive oral anti-coagulants, helping prevent strokes.
Read Moreby Selina McKee | Feb 15, 2018 | News | 0
The NHS has launched a new device in England designed to accelerate the diagnosis of atrial fibrillation (AF), the most common arrhythmia and a contributing factor of up to one in five strokes in the UK.
Read Moreby Selina McKee | Aug 2, 2016 | News | 0
The National Institute for Health and Care Excellence has published new indicators for healthcare professionals that could prevent thousands of people from having a stroke.
Read Moreby Selina McKee | May 10, 2016 | News | 0
The chance of receiving recommended therapies to reduce the risk of stroke varies 16-fold across England, finds a new report published by the Association of the British Pharmaceutical Industry’s Stroke in Atrial Fibrillation Initiative.
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
